Allergan AGN will be releasing its next round of earnings Thursday. For all of the relevant information, here is your guide for Thursday's Q2 earnings announcement.
Earnings and Revenue
Allergan earnings will be near $4.12 per share on sales of $3.91 billion, according to analysts.
In the same quarter last year, Allergan reported EPS of $4.02 on revenue of $4.01 billion. If the company were to match the consensus estimate when it reports Thursday, EPS would be up 2.49 percent. Sales would have fallen 2.42 percent from the same quarter last year. Allergan's reported EPS has stacked up against analyst estimates in the past like this:
| Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
| EPS Estimate | 3.36 | 4.73 | 4.07 | 3.93 |
| EPS Actual | 3.74 | 4.86 | 4.15 | 4.02 |
Stock Performance
Over the past 52-week period, shares of Allergan have declined 30.29 percent. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. Analysts seem to have settled on a Neutral rating with Allergan. The strength of this rating has maintained conviction over the past three months.
Conference Call
Allergan's Q2 conference call is scheduled to begin at 8:30 a.m. ET and can be accessed here: https://www.allergan.com/investors/events-presentations
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
